Copyright
©The Author(s) 2025.
World J Stem Cells. Dec 26, 2025; 17(12): 112778
Published online Dec 26, 2025. doi: 10.4252/wjsc.v17.i12.112778
Published online Dec 26, 2025. doi: 10.4252/wjsc.v17.i12.112778
Table 1 Characteristics table of the included studies
| Ref. | Country | Study type | Intervention | Control | Sample size (I/C) | Age (I/C) | Sex ratio (M:F, I/C) | KL grade (I/C) | Outcome measures | Follow-up duration |
| Hernigou et al[19], 2021 | France | PCS | BMAC SC | TKR | 140/140 | 75.4 (range 65-90) | 53:87 | Grade 2-4/grade 2-4 | KSS, BML volume, HKA angle | Approximately 15 years |
| Hernigou et al[17], 2021 | France | RCT | BMAC SC | BMAC IA alone | 60/60 | 64 ± 21 | 25:35/25:35 | Grade 1-4/grade 1-4 | KSS, MRI | Approximately 15 years |
| Madrazo-Ibarra et al[18], 2022 | India | RCT | BMAC SC | Placebo | 25/25 | 63.2 ± 8.2/66.5 ± 5.3 | 14:11/12:13 | Grade 3 & 4/grade 3 & 4 | KOOS, VAS | 12 months |
| Silva et al[16], 2022 | Italy | RCT | BMAC SC + IA | BMAC IA alone | 43/43 | NR | NR | Grade 3 & 4/grade 3 & 4 | WOMAC, Tegner, IKDC, EQ-VAS | 12 months |
| Kon et al[15], 2023 | France | PCS | BMAC SC | None | 30/NIL | 56.4 ± 8.1 | 19:11 | Grade 2 & 3/NIL | IKDC, KOOS, WORMS MRI | 24 months |
- Citation: Nallakumarasamy A, Shrivastava S, Rangarajan RV, Jeyaraman N, Devadas AG, Ramasubramanian S, Muthu S, Bapat A, Jeyaraman M. Does standalone/combined subchondral bone marrow-derived mesenchymal stem/stromal cell injection offer significantly better clinical benefit to intraarticular injection in knee osteoarthritis? World J Stem Cells 2025; 17(12): 112778
- URL: https://www.wjgnet.com/1948-0210/full/v17/i12/112778.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v17.i12.112778
